Dr. Safana Salim Al Saidi, a chemical pathologist. – ” ONA

Muscat: A chemical pathologist in the Ministry of Health has succeeded in validating a new marker which helps in early prostate cancer diagnosis. Dr. Safana Salim Al Saidi, a chemical pathologist worked along with her team from the MoH, the Sultan Qaboos University Hospital and the Research Council , under the supervision of Dr. Waad Allah Mula, Professor at the Royal Hospital for Clinical Biochemistry.

Far Fewer Men Being Treated for Prostate Cancer

The number of older Americans treated for prostate cancer plummeted 42 percent since health officials began questioning the benefits of screening tests, a new study shows. The finding points to the success of efforts to curtail the use of controversial prostate-specific antigen, or PSA, screening tests, said lead author Dr. Tudor Borza.